Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360237
Status:
AVAILABLE
Last Update Posted:
2024-04-11
First Post:
2024-04-06
Brief Title:
Olezarsen Early Access Program for Patients With Familial Chylomicronemia Syndrome FCS
Sponsor:
Ionis Pharmaceuticals Inc
Organization:
Ionis Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Familial Chylomicronemia Syndrome |
Keywords:
| Name | View |
|---|---|
| Genetic Diseases Inborn | View |
| Familial Chylomicronemia | View |
| Familial Lipoprotein Lipase Deficiency | View |
| Hyperlipoproteinemias | View |
| Familial Hyperlipoproteinemia Type 1 | View |
| Hyperlipoproteinemia Type 1 | View |
| Hyperchylomicronemia Familial | View |
| Lipoprotein Lipase Deficiency Familial | View |
| Hyperlipidemias | View |
| Dyslipidemias | View |
| Lipid Metabolism Disorders | View |
| Lipid Metabolism Inborn Errors | View |
| Metabolic Diseases | View |
| Metabolism Inborn Errors | View |